joimax®’s leadership transition marks a new era of innovation and continuity in the field of endoscopic spine surgery. With the appointment of Maximilian Ries as Chief Executive Officer and the transition of Founder Wolfgang Ries to Executive Chairman, the company is strategically positioning itself to accelerate the advancement of its minimally invasive surgical technologies. Wolfgang Ries, who has been at the forefront of developing cutting-edge techniques for nearly two and a half decades, will now focus on research and education through ESPINEA®, the only Royal College of Surgeons-accredited training academy dedicated to endoscopic spine surgery.
The expanded leadership and commercial operations in the U.S. reflect joimax®’s commitment to increasing access and adoption of its technologies across a rapidly evolving surgical landscape. With key leadership promotions—such as Anthony Troncale as President and Dr. Levon Zanadvorov as Medical Director—joimax® is enhancing clinical engagement, educational support, and sales execution. The company’s endoscopic systems are used by spine surgeons worldwide for less invasive treatment of herniated discs and spinal stenosis, helping reduce patient trauma, shorten hospital stays, and lower post-operative risks.
This strategic realignment reinforces joimax®’s role as a global leader in minimally invasive spinal care, ready to meet rising demand with robust clinical, operational, and educational capabilities. By combining a strong heritage of innovation with a dynamic new leadership team, joimax® is poised to scale its impact across international markets, particularly in the U.S. where the need for efficient, patient-centered spinal interventions is growing. As endoscopic techniques become increasingly adopted as standard practice, joimax® continues to lead the way—setting benchmarks for excellence, training, and transformative patient outcomes.
MedTech Soectrum's Summary
Strategic Leadership Continuity: The appointment of Maximilian Ries as CEO ensures a seamless transition and continued innovation, leveraging his deep experience within joimax® to drive future growth in endoscopic spine surgery.
Strengthened U.S. Operations: With a bolstered U.S. commercial leadership team, joimax® is well-positioned to expand market presence and meet growing demand for minimally invasive spinal procedures in a key global market.
Global Innovation Momentum: Founder Wolfgang Ries’ new focus on R&D and education through ESPINEA® reinforces joimax®’s commitment to advancing surgical techniques and setting new standards in endoscopic spine care worldwide.
